Hofseth Biocare ASA (HBC) — Cash Flow Reinvestment Rate
Hofseth Biocare ASA (HBC) has a Cash Flow Reinvestment Rate of 2.87x as of December 2024, reinvesting Nkr2.44 Million (capex Nkr1.22 Million plus investments Nkr-1.22 Million) from operating cash flow of Nkr851.00K. See free cash flow generation of Hofseth Biocare ASA to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hofseth Biocare ASA Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Hofseth Biocare ASA across 2 annual periods. For the full cash flow conversion analysis, see Hofseth Biocare ASA cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hofseth Biocare ASA (2015–2023)
Year-by-year capital reinvestment analysis for Hofseth Biocare ASA. See how financially flexible is Hofseth Biocare ASA to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 9.51x | Nkr26.25 Million | Nkr2.76 Million | Nkr8.19 Million | ▲ +512.0% |
| 2015 | 1.55x | Nkr12.37 Million | Nkr7.97 Million | Nkr11.84 Million | — |